Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A Jul 21, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea Jun 3, 2022 | ASX News, Incannex Healthcare (ASX:IHL)